Last reviewed · How we verify

NCT07282275

How Does Continued Use of Green Light Therapy Impact Outcomes?

Recruiting now NA Last updated 23 December 2025
What this trial tests

NA trial testing EmeraldLED in Body Composition in 100 participants. Currently enrolling.

Timeline
21 October 2025
Primary endpoint
21 October 2026
21 October 2026

Quick facts

Lead sponsorEfforia, Inc
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment100
Start date21 October 2025
Primary completion21 October 2026
Estimated completion21 October 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Efforia, Inc — full company profile →

Who can join

18 and older, any sex, with Body Composition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Already using Green Light Therapy? Explore how continued use with twice-weekly 20-minute sessions may continue to support positive changes in body composition. Discover whether this non-invasive wellness approach gets better over time to help support energy, balance, and renewal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of EmeraldLED

Trials testing the same drug.

Other recruiting trials for Body Composition

Currently open trials in the same condition.

Other Efforia, Inc trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07282275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing